Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.71 USD | -1.50% | +3.62% | +20.97% |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
May. 07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 951M | Sales 2025 * | 1.1B | Capitalization | 5.69B |
---|---|---|---|---|---|
Net income 2024 * | 373M | Net income 2025 * | 466M | EV / Sales 2024 * | 6.93 x |
Net Debt 2024 * | 899M | Net Debt 2025 * | 422M | EV / Sales 2025 * | 5.57 x |
P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
11.6
x | Employees | 373 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.89% |
Latest transcript on Halozyme Therapeutics, Inc.
1 day | -1.50% | ||
1 week | +3.62% | ||
Current month | +17.35% | ||
1 month | +15.71% | ||
3 months | +23.85% | ||
6 months | +11.97% | ||
Current year | +20.97% |
Managers | Title | Age | Since |
---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 61 | 14-01-05 |
Nicole LaBrosse
DFI | Director of Finance/CFO | 41 | 14-12-31 |
Mark Snyder
CMP | Compliance Officer | 57 | 22-01-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
BRD | Director/Board Member | 70 | 06-07-30 |
Chairman | 59 | 15-08-04 | |
Barbara Duncan
BRD | Director/Board Member | 59 | 23-02-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.48% | 5 M€ | -1.80% | - | |
0.73% | 0 M€ | 0.00% | - | |
0.55% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 44.71 | -1.50% | 1,102,299 |
24-05-16 | 45.39 | -0.94% | 1,037,319 |
24-05-15 | 45.82 | +4.56% | 1,262,045 |
24-05-14 | 43.82 | +0.48% | 1,102,216 |
24-05-13 | 43.61 | +1.07% | 908,693 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.97% | 5.69B | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.42% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- HALO Stock